Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CRH Medical Corporation stock logo
CRHM
CRH Medical
$3.99
$3.99
$1.66
$4.01
$285.76MN/A1.04 million shs388,486 shs
FORE
Foresight Acquisition
$9.82
$8.85
$10.17
$382.64MN/A234,465 shs242 shs
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$21.42
+2.7%
$18.97
$10.31
$21.45
$625.76M2.06128,495 shs197,934 shs
THMA
Thimble Point Acquisition
$7.35
$9.01
$10.10
$2KN/A154,984 shsN/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CRH Medical Corporation stock logo
CRHM
CRH Medical
0.00%0.00%0.00%0.00%0.00%
FORE
Foresight Acquisition
0.00%0.00%0.00%0.00%0.00%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
+2.73%+7.05%+8.73%+38.02%+58.55%
THMA
Thimble Point Acquisition
0.00%0.00%0.00%0.00%-98.60%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/AN/AN/A
FORE
Foresight Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.2308 of 5 stars
1.34.00.00.01.82.53.1
THMA
Thimble Point Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/A
FORE
Foresight Acquisition
N/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
2.67
Moderate Buy$18.75-12.46% Downside
THMA
Thimble Point Acquisition
N/AN/AN/AN/A

Current Analyst Ratings

Latest FORE, CRHM, PNTG, and THMA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$18.00 ➝ $22.00
3/1/2024
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$16.00 ➝ $21.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/AN/A
FORE
Foresight Acquisition
N/AN/AN/AN/A($0.25) per shareN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$544.89M1.18$0.80 per share26.65$4.86 per share4.41
THMA
Thimble Point Acquisition
N/AN/AN/AN/A($3.12) per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/A0.00N/AN/AN/AN/AN/A
FORE
Foresight Acquisition
N/AN/A0.00N/AN/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$13.38M$0.4448.6824.912.202.46%12.78%3.36%5/2/2024 (Estimated)
THMA
Thimble Point Acquisition
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest FORE, CRHM, PNTG, and THMA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/28/202412/31/2023
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
$0.19$0.18-$0.01$0.22$136.79 million$145.95 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/AN/AN/A
FORE
Foresight Acquisition
N/AN/AN/AN/AN/A
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
N/AN/AN/AN/AN/A
THMA
Thimble Point Acquisition
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/AN/AN/A
FORE
Foresight Acquisition
N/A
0.91
0.91
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
0.44
1.12
1.12
THMA
Thimble Point Acquisition
N/A
0.29
0.29

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A
FORE
Foresight Acquisition
62.26%
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
85.88%
THMA
Thimble Point Acquisition
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CRH Medical Corporation stock logo
CRHM
CRH Medical
N/A71.62 millionN/ANot Optionable
FORE
Foresight Acquisition
240.36 millionN/ANot Optionable
The Pennant Group, Inc. stock logo
PNTG
The Pennant Group
5,79130.01 million28.63 millionOptionable
THMA
Thimble Point Acquisition
38.21 millionN/ANot Optionable

FORE, CRHM, PNTG, and THMA Headlines

SourceHeadline
NBA Odds, Betting Lines & Point Spreads - Yahoo SportsNBA Odds, Betting Lines & Point Spreads - Yahoo Sports
sports.yahoo.com - February 1 at 10:57 PM
IPXX.UN Inflection Point Acquisition Corp. II UnitsIPXX.UN Inflection Point Acquisition Corp. II Units
seekingalpha.com - September 23 at 1:25 PM
Fantasy hockey defenseman point projectionsFantasy hockey defenseman point projections
nhl.com - September 22 at 3:27 PM
Point Loma Nazarene UniversityPoint Loma Nazarene University
usnews.com - August 3 at 10:41 AM
Link Enters Singapore through the Acquisition of Jurong Point and Swing By @ Thomson PlazaLink Enters Singapore through the Acquisition of Jurong Point and Swing By @ Thomson Plaza
finance.yahoo.com - January 17 at 1:49 PM
Thimble Point Acquisition Corp. Class A NewsThimble Point Acquisition Corp. Class A News
thestreet.com - July 7 at 9:23 PM
Pear Therapeutics IncPear Therapeutics Inc
reuters.com - December 20 at 2:13 PM
Pear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue GuidancePear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue Guidance
finance.yahoo.com - December 8 at 8:32 AM
Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use DisorderPear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder
finance.yahoo.com - December 8 at 8:32 AM
Pear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx ConferencePear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx Conference
finance.yahoo.com - December 8 at 8:32 AM
Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics CompanyPear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company
finance.yahoo.com - December 8 at 8:32 AM
Pear Therapeutics Stock Rises on First Day of TradingPear Therapeutics Stock Rises on First Day of Trading
finance.yahoo.com - December 8 at 8:32 AM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Thimble Point Acquisition Corp. for Potential Breaches of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Thimble Point Acquisition Corp. for Potential Breaches of Fiduciary Duty By Its Board of Directors
prnewswire.com - August 2 at 3:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CRH Medical logo

CRH Medical

NYSE:CRHM

Foresight Acquisition

NASDAQ:FORE
Foresight Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to engage in the population health management business. The company was incorporated in 2020 and is based in Chicago, Illinois.
The Pennant Group logo

The Pennant Group

NASDAQ:PNTG
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Thimble Point Acquisition

NASDAQ:THMA
Thimble Point Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New Haven, Connecticut.